Shared brain transcriptomic signature in TDP-43 type A FTLD patients with or without GRN mutations
暂无分享,去创建一个
L. Petrucelli | Y. Asmann | R. Petersen | B. Boeve | M. Murray | D. Dickson | J. Biernacka | N. Graff-Radford | M. Baker | S. Tian | K. Josephs | N. Finch | M. Dejesus-Hernandez | Yingxue Ren | C. Pottier | M. van Blitterswijk | L. Mateiu | Björn Oskarsson | R. Rademakers | Cristina Teixeira Vicente | M. Dejesus‐Hernandez | Shulan Tian | Ligia Mateiu | Cyril Pottier
[1] Anna L. Brown,et al. Common ALS/FTD risk variants in UNC13A exacerbate its cryptic splicing and loss upon TDP-43 mislocalization , 2021, bioRxiv.
[2] Caitlin M. Rodriguez,et al. TDP-43 represses cryptic exon inclusion in the FTD–ALS gene UNC13A , 2021, Nature.
[3] K. Herrup,et al. Myelin pathology in ataxia-telangiectasia is the cell-intrinsic consequence of ATM deficiency in the oligodendrocytes , 2021, medRxiv.
[4] E. McDonagh,et al. Open Targets Platform: supporting systematic drug–target identification and prioritisation , 2020, Nucleic Acids Res..
[5] M. Martinez-Fierro,et al. The Roles of Matrix Metalloproteinases and Their Inhibitors in Human Diseases , 2020, International journal of molecular sciences.
[6] T. Carpenter,et al. GABA and glutamate deficits from frontotemporal lobar degeneration are associated with disinhibition , 2020, Brain : a journal of neurology.
[7] H. Cao,et al. Single-nucleus transcriptome analysis reveals dysregulation of angiogenic endothelial cells and neuroprotective glia in Alzheimer’s disease , 2020, Proceedings of the National Academy of Sciences.
[8] Michelle K. Cahill,et al. Neurotoxic microglia promote TDP-43 proteinopathy in progranulin deficiency , 2020, Nature.
[9] Anna L. Brown,et al. Truncated stathmin-2 is a marker of TDP-43 pathology in frontotemporal dementia. , 2020, The Journal of clinical investigation.
[10] Y. Asmann,et al. Loss of TMEM106B leads to myelination deficits: implications for frontotemporal dementia treatment strategies. , 2020, Brain : a journal of neurology.
[11] R. Vandenberghe,et al. Distinct molecular patterns of TDP-43 pathology in Alzheimer’s disease: relationship with clinical phenotypes , 2020, Acta Neuropathologica Communications.
[12] Y. Asmann,et al. Deciphering cellular transcriptional alterations in Alzheimer’s disease brains , 2020, bioRxiv.
[13] M. Humphries,et al. KANK2 Links αVβ5 Focal Adhesions to Microtubules and Regulates Sensitivity to Microtubule Poisons and Cell Migration , 2020, Frontiers in Cell and Developmental Biology.
[14] L. Petrucelli,et al. Extensive transcriptomic study emphasizes importance of vesicular transport in C9orf72 expansion carriers , 2019, Acta Neuropathologica Communications.
[15] B. Brüne,et al. Sphingosine-1-Phosphate and Macrophage Biology—How the Sphinx Tames the Big Eater , 2019, Front. Immunol..
[16] E. Englund,et al. A cortical microvascular structure in vascular dementia, Alzheimer's disease, frontotemporal lobar degeneration and nondemented controls: a sign of angiogenesis due to brain ischaemia? , 2019, Neuropathology and applied neurobiology.
[17] Olga Tanaseichuk,et al. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets , 2019, Nature Communications.
[18] Artur Lugmayr,et al. CirGO: an alternative circular way of visualising gene ontology terms , 2019, BMC Bioinformatics.
[19] Kevin F. Bieniek,et al. Genome-wide analyses as part of the international FTLD-TDP whole-genome sequencing consortium reveals novel disease risk factors and increases support for immune dysfunction in FTLD , 2019, Acta Neuropathologica.
[20] Michael J. Steinbaugh,et al. ALS IMPLICATED PROTEIN TDP-43 SUSTAINS LEVELS OF STMN2 A MEDIATOR OF MOTOR NEURON GROWTH AND REPAIR , 2019, Nature Neuroscience.
[21] F. Rigo,et al. Premature polyadenylation-mediated loss of stathmin-2 is a hallmark of TDP-43-dependent neurodegeneration , 2018, Nature Neuroscience.
[22] C. Jack,et al. Pathological, imaging and genetic characteristics support the existence of distinct TDP-43 types in non-FTLD brains , 2019, Acta Neuropathologica.
[23] Rajendra K. Sharma,et al. Calmodulin-binding proteins: A journey of 40 years. , 2018, Cell calcium.
[24] K. Nave,et al. Cell-autonomous requirement of TDP-43, an ALS/FTD signature protein, for oligodendrocyte survival and myelination , 2018, Proceedings of the National Academy of Sciences.
[25] Ying Sun,et al. Progranulin associates with hexosaminidase A and ameliorates GM2 ganglioside accumulation and lysosomal storage in Tay-Sachs disease , 2018, Journal of Molecular Medicine.
[26] R. Faull,et al. Gamma-aminobutyric acid A receptors in Alzheimer's disease: highly localized remodeling of a complex and diverse signaling pathway , 2018, Neural regeneration research.
[27] R. Sandhoff,et al. Emerging concepts of ganglioside metabolism , 2018, FEBS letters.
[28] Panos Roussos,et al. Brain Cell Type Specific Gene Expression and Co-expression Network Architectures , 2018, Scientific Reports.
[29] Kevin F. Bieniek,et al. Potential genetic modifiers of disease risk and age at onset in patients with frontotemporal lobar degeneration and GRN mutations: a genome-wide association study , 2018, Lancet Neurology.
[30] S. Leurgans,et al. Frontotemporal dysregulation of the SNARE protein interactome is associated with faster cognitive decline in old age , 2018, Neurobiology of Disease.
[31] J. Ji,et al. S1PR3 is essential for phosphorylated fingolimod to protect astrocytes against oxygen‐glucose deprivation‐induced neuroinflammation via inhibiting TLR2/4‐NFκB signalling , 2018, Journal of cellular and molecular medicine.
[32] R. Proia,et al. Sphingosine-1-Phosphate and the S1P3 Receptor Initiate Neuronal Retraction via RhoA/ROCK Associated with CRMP2 Phosphorylation , 2017, Front. Mol. Neurosci..
[33] W. Seeley,et al. Impaired prosaposin lysosomal trafficking in frontotemporal lobar degeneration due to progranulin mutations , 2017, Nature Communications.
[34] G. Halliday,et al. Gene therapy for Parkinson's disease: Disease modification by GDNF family of ligands , 2017, Neurobiology of Disease.
[35] J. Trojanowski,et al. Expansion of the classification of FTLD-TDP: distinct pathology associated with rapidly progressive frontotemporal degeneration , 2017, Acta Neuropathologica.
[36] S. Leurgans,et al. Presynaptic proteins complexin-I and complexin-II differentially influence cognitive function in early and late stages of Alzheimer’s disease , 2017, Acta Neuropathologica.
[37] Ying Sun,et al. Progranulin Recruits HSP70 to β-Glucocerebrosidase and Is Therapeutic Against Gaucher Disease , 2016, EBioMedicine.
[38] S. Rollinson,et al. Identification of biological pathways regulated by PGRN and GRN peptide treatments using transcriptome analysis , 2016, The European journal of neuroscience.
[39] Tanya M. Teslovich,et al. Prosaposin is a regulator of progranulin levels and oligomerization , 2016, Nature Communications.
[40] Michelle K. Cahill,et al. Progranulin Deficiency Promotes Circuit-Specific Synaptic Pruning by Microglia via Complement Activation , 2016, Cell.
[41] Eric Karran,et al. The Cellular Phase of Alzheimer’s Disease , 2016, Cell.
[42] S. Rombouts,et al. Cerebral blood flow in presymptomatic MAPT and GRN mutation carriers: A longitudinal arterial spin labeling study☆ , 2016, NeuroImage: Clinical.
[43] N. Belluardo,et al. Current disease modifying approaches to treat Parkinson’s disease , 2016, Cellular and Molecular Life Sciences.
[44] L. Petrucelli,et al. TAR DNA‐binding protein 43 and pathological subtype of Alzheimer's disease impact clinical features , 2015, Annals of neurology.
[45] Ying Sun,et al. Prosaposin facilitates sortilin-independent lysosomal trafficking of progranulin , 2015, The Journal of cell biology.
[46] L. Reid,et al. Motor pathway degeneration in young ataxia telangiectasia patients: A diffusion tractography study , 2015, NeuroImage: Clinical.
[47] M. Sperandio,et al. Sphingosine-1-phosphate receptor 3 promotes leukocyte rolling by mobilizing endothelial P-selectin , 2015, Nature Communications.
[48] P. Byrd,et al. Ataxia telangiectasia: more variation at clinical and cellular levels , 2015, Clinical genetics.
[49] T. Kubo,et al. Knock Out of S1P3 Receptor Signaling Attenuates Inflammation and Fibrosis in Bleomycin-Induced Lung Injury Mice Model , 2014, PloS one.
[50] Mike P. Wattjes,et al. Distinct perfusion patterns in Alzheimer’s disease, frontotemporal dementia and dementia with Lewy bodies , 2014, European Radiology.
[51] Alexander Gerhard,et al. Frontotemporal dementia and its subtypes: a genome-wide association study , 2014, The Lancet Neurology.
[52] Hee-Sun Kim,et al. The anti-inflammatory role of tissue inhibitor of metalloproteinase-2 in lipopolysaccharide-stimulated microglia , 2014, Journal of Neuroinflammation.
[53] H. Wilms,et al. Glial Cell Line-Derived Neurotrophic Factor Family Members Reduce Microglial Activation via Inhibiting p38MAPKs-Mediated Inflammatory Responses , 2014, Journal of neurodegenerative diseases.
[54] R. Petersen,et al. Progranulin protein levels are differently regulated in plasma and CSF , 2014, Neurology.
[55] K. Sandhoff,et al. Sphingolipids and lysosomal pathologies. , 2014, Biochimica et biophysica acta.
[56] C. Jack,et al. TDP-43 is a key player in the clinical features associated with Alzheimer’s disease , 2014, Acta Neuropathologica.
[57] R. Bartus,et al. Parkinson's Disease Gene Therapy: Success by Design Meets Failure by Efficacy , 2013, Molecular therapy : the journal of the American Society of Gene Therapy.
[58] Andreas Krämer,et al. Causal analysis approaches in Ingenuity Pathway Analysis , 2013, Bioinform..
[59] Wei Shi,et al. featureCounts: an efficient general purpose program for assigning sequence reads to genomic features , 2013, Bioinform..
[60] H. Voss,et al. Progranulin Deficiency Promotes Post-Ischemic Blood–Brain Barrier Disruption , 2013, The Journal of Neuroscience.
[61] D. Cleveland,et al. Converging Mechanisms in ALS and FTD: Disrupted RNA and Protein Homeostasis , 2013, Neuron.
[62] L. S. Sefcik,et al. Sphingosine 1-phosphate receptor 3 regulates recruitment of anti-inflammatory monocytes to microvessels during implant arteriogenesis , 2013, Proceedings of the National Academy of Sciences.
[63] A. Bateman,et al. Expression of the Growth Factor Progranulin in Endothelial Cells Influences Growth and Development of Blood Vessels: A Novel Mouse Model , 2013, PloS one.
[64] James B. Rowe,et al. Reorganisation of brain networks in frontotemporal dementia and progressive supranuclear palsy☆ , 2013, NeuroImage: Clinical.
[65] J. Chun,et al. Lysophospholipids and their receptors in the central nervous system. , 2013, Biochimica et biophysica acta.
[66] Thomas R. Gingeras,et al. STAR: ultrafast universal RNA-seq aligner , 2013, Bioinform..
[67] Yi Zhong,et al. Digital sorting of complex tissues for cell type-specific gene expression profiles , 2013, BMC Bioinformatics.
[68] Wei Li,et al. RSeQC: quality control of RNA-seq experiments , 2012, Bioinform..
[69] Davis J. McCarthy,et al. Differential expression analysis of multifactor RNA-Seq experiments with respect to biological variation , 2012, Nucleic acids research.
[70] R. Faull,et al. Population-specific expression analysis (PSEA) reveals molecular changes in diseased brain , 2011, Nature Methods.
[71] Bruce L. Miller,et al. Expanded GGGGCC Hexanucleotide Repeat in Noncoding Region of C9ORF72 Causes Chromosome 9p-Linked FTD and ALS , 2011, Neuron.
[72] David Heckerman,et al. A Hexanucleotide Repeat Expansion in C9ORF72 Is the Cause of Chromosome 9p21-Linked ALS-FTD , 2011, Neuron.
[73] Matko Bosnjak,et al. REVIGO Summarizes and Visualizes Long Lists of Gene Ontology Terms , 2011, PloS one.
[74] J. Trojanowski,et al. A harmonized classification system for FTLD-TDP pathology , 2011, Acta Neuropathologica.
[75] H. Feldman,et al. rs5848 polymorphism and serum progranulin level , 2011, Journal of the Neurological Sciences.
[76] D. Selkoe. Alzheimer's disease. , 2011, Cold Spring Harbor perspectives in biology.
[77] Longxuan Li,et al. Microglial activation state exerts a biphasic influence on brain endothelial cell proliferation by regulating the balance of TNF and TGF-β1 , 2010, Journal of Neuroinflammation.
[78] J. Trojanowski,et al. Distinct cerebral perfusion patterns in FTLD and AD , 2010, Neurology.
[79] G. Bing,et al. Glial cell line-derived neurotrophic factor protects midbrain dopaminergic neurons against lipopolysaccharide neurotoxicity , 2010, Journal of Neuroimmunology.
[80] M. J. Fresnadillo Martínez,et al. Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions , 2010, Nature Genetics.
[81] Norbert Schuff,et al. Concordance and Discordance Between Brain Perfusion and Atrophy in Frontotemporal Dementia , 2010, Brain Imaging and Behavior.
[82] J. Trojanowski,et al. Brain progranulin expression in GRN-associated frontotemporal lobar degeneration , 2009, Acta Neuropathologica.
[83] Steve Horvath,et al. WGCNA: an R package for weighted correlation network analysis , 2008, BMC Bioinformatics.
[84] R. Petersen,et al. Common variation in the miR-659 binding-site of GRN is a major risk factor for TDP43-positive frontotemporal dementia , 2008, Human molecular genetics.
[85] T. Kohriyama,et al. White matter lesions in the brain with frontotemporal lobar degeneration with motor neuron disease: TDP-43-immunopositive inclusions co-localize with p62, but not ubiquitin , 2008, Acta Neuropathologica.
[86] J. Trojanowski,et al. Variations in the progranulin gene affect global gene expression in frontotemporal lobar degeneration. , 2008, Human molecular genetics.
[87] C. Saper,et al. Prostaglandin E2 Attenuates Preoptic Expression of GABAA Receptors via EP3 Receptors* , 2008, Journal of Biological Chemistry.
[88] M. Lavin,et al. ATM Activation and DNA Damage Response , 2007, Cell cycle.
[89] Murray Grossman,et al. TDP-43-Positive White Matter Pathology in Frontotemporal Lobar Degeneration With Ubiquitin-Positive Inclusions , 2007, Journal of neuropathology and experimental neurology.
[90] G. van Echten-Deckert,et al. Sphingolipid metabolism in neural cells. , 2006, Biochimica et biophysica acta.
[91] H. Feldman,et al. The neuropathology of frontotemporal lobar degeneration caused by mutations in the progranulin gene. , 2006, Brain : a journal of neurology.
[92] N. Schuff,et al. Hypoperfusion in frontotemporal dementia and Alzheimer disease by arterial spin labeling MRI , 2006, Neurology.
[93] C. Duijn,et al. Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21 , 2006, Nature.
[94] S. Melquist,et al. Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17 , 2006, Nature.
[95] S. Tzeng,et al. Regulation of microglial activities by glial cell line derived neurotrophic factor , 2006, Journal of cellular biochemistry.
[96] Yosef Shiloh,et al. Ataxia-telangiectasia and the ATM gene: Linking neurodegeneration, immunodeficiency, and cancer to cell cycle checkpoints , 1996, Journal of Clinical Immunology.
[97] P. Shannon,et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. , 2003, Genome research.
[98] I. Goldberg,et al. Complex roles of tissue inhibitors of metalloproteinases in cancer , 2002, Oncogene.
[99] T. Südhof,et al. Three-Dimensional Structure of the Complexin/SNARE Complex , 2002, Neuron.
[100] J. Gu,et al. Integrin α1β1-Mediated Activation of Cyclin-Dependent Kinase 5 Activity Is Involved in Neurite Outgrowth and Human Neurofilament Protein H Lys-Ser-Pro Tail Domain Phosphorylation , 2000, The Journal of Neuroscience.
[101] K. Khanna. Cancer risk and the ATM gene: a continuing debate. , 2000, Journal of the National Cancer Institute.
[102] I. Ferrer. Neurons and Their Dendrites in Frontotemporal Dementia , 1999, Dementia and Geriatric Cognitive Disorders.
[103] Ronald C. Petersen,et al. Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17 , 1998, Nature.
[104] D. Toriumi,et al. Peripheral nerve regeneration: comparison of laminin and acidic fibroblast growth factor. , 1998, American journal of otolaryngology.
[105] C. Deng,et al. Atm selectively regulates distinct p53-dependent cell-cycle checkpoint and apoptotic pathways , 1997, Nature Genetics.
[106] Thomas C. Südhof,et al. Complexins: Cytosolic proteins that regulate SNAP receptor function , 1995, Cell.
[107] Paul Tempst,et al. SNAP receptors implicated in vesicle targeting and fusion , 1993, Nature.
[108] Richard O. Hynes,et al. Integrins: Versatility, modulation, and signaling in cell adhesion , 1992, Cell.
[109] J. Rothman,et al. SNAPs, a family of NSF attachment proteins involved in intracellular membrane fusion in animals and yeast , 1990, Cell.
[110] M. Hemler. VLA proteins in the integrin family: structures, functions, and their role on leukocytes. , 1990, Annual review of immunology.
[111] B. M. Klichev. [Conservative treatment of rectal prolapse in children]. , 1989, Pediatriia.
[112] K. Reid,et al. Subunit composition and structure of subcomponent C1q of the first component of human complement. , 1976, The Biochemical journal.